Harvard Bioscience Pre-Tax Profit Margin 2010-2023 | HBIO

Harvard Bioscience pre-tax profit margin from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Harvard Bioscience Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2023-12-31 $0.11B $-0.00B -2.68%
2023-09-30 $0.11B $-0.00B -2.68%
2023-06-30 $0.11B $-0.01B -6.14%
2023-03-31 $0.11B $-0.00B -1.75%
2022-12-31 $0.11B $-0.01B -8.85%
2022-09-30 $0.12B $-0.01B -6.78%
2022-06-30 $0.12B $-0.00B -2.48%
2022-03-31 $0.12B $-0.01B -5.79%
2021-12-31 $0.12B $-0.00B -0.84%
2021-09-30 $0.12B $-0.00B -2.56%
2021-06-30 $0.11B $-0.00B -3.60%
2021-03-31 $0.11B $-0.00B -3.81%
2020-12-31 $0.10B $-0.01B -6.86%
2020-09-30 $0.10B $-0.01B -5.88%
2020-06-30 $0.11B $-0.01B -7.62%
2020-03-31 $0.11B $-0.01B -7.14%
2019-12-31 $0.12B $-0.01B -5.17%
2019-09-30 $0.12B $-0.01B -5.04%
2019-06-30 $0.12B $-0.00B -3.31%
2019-03-31 $0.12B $-0.01B -4.07%
2018-12-31 $0.12B $-0.01B -6.56%
2018-09-30 $0.11B $-0.01B -7.27%
2018-06-30 $0.10B $-0.01B -8.00%
2018-03-31 $0.09B $-0.01B -8.05%
2017-12-31 $0.08B $-0.00B -3.85%
2017-09-30 $0.08B $-0.00B -4.88%
2017-06-30 $0.09B $-0.00B -4.55%
2017-03-31 $0.10B $-0.00B -4.21%
2016-12-31 $0.10B $-0.00B -2.88%
2016-09-30 $0.11B $-0.00B -1.89%
2016-06-30 $0.11B $-0.00B -1.87%
2016-03-31 $0.11B $-0.00B -0.91%
2015-12-31 $0.11B $-0.00B -2.75%
2015-09-30 $0.11B $-0.00B -1.80%
2015-06-30 $0.11B 0 0.00%
2015-03-31 $0.11B $0.00B 0.93%
2014-12-31 $0.11B $0.00B 3.70%
2014-09-30 $0.11B $0.00B 1.89%
2014-06-30 $0.11B $0.00B 0.94%
2014-03-31 $0.11B 0 0.00%
2013-12-31 $0.11B 0 0.00%
2013-09-30 $0.11B $0.01B 5.71%
2013-06-30 $0.11B $0.01B 5.66%
2013-03-31 $0.11B $0.01B 6.48%
2012-12-31 $0.11B $0.01B 6.36%
2012-09-30 $0.11B $0.01B 4.50%
2012-06-30 $0.11B $0.01B 4.50%
2012-03-31 $0.11B $0.01B 5.45%
2011-12-31 $0.11B $0.01B 6.48%
2011-09-30 $0.11B $0.01B 6.42%
2011-06-30 $0.11B $0.01B 8.26%
2011-03-31 $0.11B $0.01B 8.33%
2010-12-31 $0.11B $0.01B 9.26%
2010-09-30 $0.11B $0.01B 12.26%
2010-06-30 $0.10B $0.01B 11.88%
2010-03-31 $0.09B $0.01B 10.75%
2009-12-31 $0.09B $0.01B 10.47%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.167B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.777B 32.88
Bruker (BRKR) United States $10.180B 28.36
Kewaunee Scientific (KEQU) United States $0.100B 11.81